IPOs this week : July 13 - 10, 20 (wk 29)

IPOs expected to price

• Financial software provider NCino (NCNO) on July 13. The fast-growing company is looking to raise $175M. 
• GoHealth (GOCO), Relay Therapeutics (RLAY) and Trean Insurance Group (TIG) could also go public this week. 

IPO lockup expirations

• Immunovant (NASDAQ:IMVT) on July 13, 
• Phoenix Tree Holdings Limited (NYSE:DNK), Velocity Financial (NYSE:VEL) and Lizhi (NASDAQ:LIZI) on July 15 and 
• DouYu (NASDAQ:DOYU) on July 16. 

IPO quiet period expirations

• There are quiet expirations on Royalty Pharma (NASDAQ:RPRX), VerifyMe (NASDAQ:VRME), Repare Therapeutics (NASDAQ:RPTX) and Progenity (NASDAQ:PROG). 

The list of companies set to start trading in Hong Kong next week includes Archosaur Games, China Bohai Bank, Shandong Fengxiang and Cathay Media & Education Group.

IPOs this week : Feb 10 - 14, 20 (wk 7)

IPOs expected to price
A quiet week for IPO pricings is set up with only

• small-caps Huize (HUIZ) on February 11 and 
• Revolution Medicines (RVMD) on February 12 on the calendar. 

IPO quiet period expirations
Analyst quiet period expirations during the week include

• Phoenix Tree (NYSE:DNK), I-Mab (NASDAQ:IMAB), Velocity Financial (NYSE:VEL) and Lizhi (NASDAQ:LIZI) on February 11.

IPO lockup expirations
IPO lockup periods expire for

• China Xiangtai Food (NASDAQ:PLIN) on February 10 and 
• 9F (NASDAQ:JFU) on February 11.

IPOs this week : Jan 13 - 17, 20

IPOs expected to price
The IPO market slowly starts to heat up again with Phoenix Tree (DNK), Velocity Financial (VEL), I-Mab (IMAB) and Lizhi (LIZI) all expected to price. The four IPOs are on the smaller size, with only real estate finance player Velocity Financial expected to bring in more than $130M.

IPO quiet period expirations
There are also quiet period expirations on Monopar Therapeutics (NASDAQ:MNPR) and Indonesia Energy (INDO) to track.

IPO lockup expirations
IPO share lockup periods expire for

• DouYu International (NASDAQ:DOYU), Assetmark Financial (NYSE:AMK), Phreesia (NYSE:PHR), Mirum Pharmaceuticals (NASDAQ:MIRM) and Fulcrum Therapeutics (NASDAQ:FULC) on January 14 as well as 
• Intercorp Financial (NYSE:IFS), Medallia (NYSE:MDLA), Afya (NASDAQ:AFYA) and Innate Pharma (NASDAQ:IPHA) on January 16.